Multi-targeting bispecific antigen binding molecules with increased selectivity
The present invention provides a multi-targeting bispecific antigen-binding molecule characterized by comprising a first and a second bispecific entity, each entity comprising a domain that binds to a target, a second domain that binds to an extracellular epitope of human and macaque CD3 epsilon cha...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | WEBERHOF CHRISTIAN BRUMMEL CHRISTIAN RAUM TOBIAS BAILIS JULIE EVOETS STEVEN S. WEDLER FAN ERIC KLINGER MARKUS WAHL JOACHIM THOMAS OLIVER BROSE JOHN ZALESKI ADAM LATEBIS PAUL D 'ANGELO IVAN LOWE DAVID MOOZ MICHAEL BOEHM THOMAS NEGELE VOLKER KUFER PETER RATH BENEDIKT ULRICH INGMAR |
description | The present invention provides a multi-targeting bispecific antigen-binding molecule characterized by comprising a first and a second bispecific entity, each entity comprising a domain that binds to a target, a second domain that binds to an extracellular epitope of human and macaque CD3 epsilon chains wherein the two bispecific entities are linked to each other by a spacer, the spacer separates the first and second bispecific entities. In addition, the invention provides polynucleotides encoding the multi-targeting bispecific antigen binding molecules, vectors comprising such polynucleotides, host cells expressing constructs, and pharmaceutical compositions comprising the same.
本发明提供了多靶向性双特异性抗原结合分子,其特征在于包含第一和第二双特异性实体,每个实体包含与靶标结合的结构域、与人和猕猴CD3ε链的细胞外表位结合的第二结构域,其中两个双特异性实体通过间隔物彼此连接,该间隔物将第一和第二双特异性实体间隔开。此外,本发明提供了编码该多靶向性双特异性抗原结合分子的多核苷酸、包含这种多核苷酸的载体、表达构建体的宿主细胞、以及包含其的药物组合物。 |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN116323671A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN116323671A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN116323671A3</originalsourceid><addsrcrecordid>eNqNirEKwkAQBa-xEPUfzg9IcR7EWoJiozb24by8xIVzc2Q3in9vBD_AamBm5uZyGpNSoWHooMSdvZFkRGop2sBKHXhS3HzTo0-IY4LYF-ndEscBQdBYwRSUnqTvpZm1IQlWPy7M-rC_VscCua8hOUQwtK7OzpV-48ut2_l_ng-_0zfJ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Multi-targeting bispecific antigen binding molecules with increased selectivity</title><source>esp@cenet</source><creator>WEBERHOF CHRISTIAN ; BRUMMEL CHRISTIAN ; RAUM TOBIAS ; BAILIS JULIE ; EVOETS STEVEN ; S. WEDLER ; FAN ERIC ; KLINGER MARKUS ; WAHL JOACHIM ; THOMAS OLIVER ; BROSE JOHN ; ZALESKI ADAM ; LATEBIS PAUL ; D 'ANGELO IVAN ; LOWE DAVID ; MOOZ MICHAEL ; BOEHM THOMAS ; NEGELE VOLKER ; KUFER PETER ; RATH BENEDIKT ; ULRICH INGMAR</creator><creatorcontrib>WEBERHOF CHRISTIAN ; BRUMMEL CHRISTIAN ; RAUM TOBIAS ; BAILIS JULIE ; EVOETS STEVEN ; S. WEDLER ; FAN ERIC ; KLINGER MARKUS ; WAHL JOACHIM ; THOMAS OLIVER ; BROSE JOHN ; ZALESKI ADAM ; LATEBIS PAUL ; D 'ANGELO IVAN ; LOWE DAVID ; MOOZ MICHAEL ; BOEHM THOMAS ; NEGELE VOLKER ; KUFER PETER ; RATH BENEDIKT ; ULRICH INGMAR</creatorcontrib><description>The present invention provides a multi-targeting bispecific antigen-binding molecule characterized by comprising a first and a second bispecific entity, each entity comprising a domain that binds to a target, a second domain that binds to an extracellular epitope of human and macaque CD3 epsilon chains wherein the two bispecific entities are linked to each other by a spacer, the spacer separates the first and second bispecific entities. In addition, the invention provides polynucleotides encoding the multi-targeting bispecific antigen binding molecules, vectors comprising such polynucleotides, host cells expressing constructs, and pharmaceutical compositions comprising the same.
本发明提供了多靶向性双特异性抗原结合分子,其特征在于包含第一和第二双特异性实体,每个实体包含与靶标结合的结构域、与人和猕猴CD3ε链的细胞外表位结合的第二结构域,其中两个双特异性实体通过间隔物彼此连接,该间隔物将第一和第二双特异性实体间隔开。此外,本发明提供了编码该多靶向性双特异性抗原结合分子的多核苷酸、包含这种多核苷酸的载体、表达构建体的宿主细胞、以及包含其的药物组合物。</description><language>chi ; eng</language><subject>CHEMISTRY ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230623&DB=EPODOC&CC=CN&NR=116323671A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230623&DB=EPODOC&CC=CN&NR=116323671A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>WEBERHOF CHRISTIAN</creatorcontrib><creatorcontrib>BRUMMEL CHRISTIAN</creatorcontrib><creatorcontrib>RAUM TOBIAS</creatorcontrib><creatorcontrib>BAILIS JULIE</creatorcontrib><creatorcontrib>EVOETS STEVEN</creatorcontrib><creatorcontrib>S. WEDLER</creatorcontrib><creatorcontrib>FAN ERIC</creatorcontrib><creatorcontrib>KLINGER MARKUS</creatorcontrib><creatorcontrib>WAHL JOACHIM</creatorcontrib><creatorcontrib>THOMAS OLIVER</creatorcontrib><creatorcontrib>BROSE JOHN</creatorcontrib><creatorcontrib>ZALESKI ADAM</creatorcontrib><creatorcontrib>LATEBIS PAUL</creatorcontrib><creatorcontrib>D 'ANGELO IVAN</creatorcontrib><creatorcontrib>LOWE DAVID</creatorcontrib><creatorcontrib>MOOZ MICHAEL</creatorcontrib><creatorcontrib>BOEHM THOMAS</creatorcontrib><creatorcontrib>NEGELE VOLKER</creatorcontrib><creatorcontrib>KUFER PETER</creatorcontrib><creatorcontrib>RATH BENEDIKT</creatorcontrib><creatorcontrib>ULRICH INGMAR</creatorcontrib><title>Multi-targeting bispecific antigen binding molecules with increased selectivity</title><description>The present invention provides a multi-targeting bispecific antigen-binding molecule characterized by comprising a first and a second bispecific entity, each entity comprising a domain that binds to a target, a second domain that binds to an extracellular epitope of human and macaque CD3 epsilon chains wherein the two bispecific entities are linked to each other by a spacer, the spacer separates the first and second bispecific entities. In addition, the invention provides polynucleotides encoding the multi-targeting bispecific antigen binding molecules, vectors comprising such polynucleotides, host cells expressing constructs, and pharmaceutical compositions comprising the same.
本发明提供了多靶向性双特异性抗原结合分子,其特征在于包含第一和第二双特异性实体,每个实体包含与靶标结合的结构域、与人和猕猴CD3ε链的细胞外表位结合的第二结构域,其中两个双特异性实体通过间隔物彼此连接,该间隔物将第一和第二双特异性实体间隔开。此外,本发明提供了编码该多靶向性双特异性抗原结合分子的多核苷酸、包含这种多核苷酸的载体、表达构建体的宿主细胞、以及包含其的药物组合物。</description><subject>CHEMISTRY</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNirEKwkAQBa-xEPUfzg9IcR7EWoJiozb24by8xIVzc2Q3in9vBD_AamBm5uZyGpNSoWHooMSdvZFkRGop2sBKHXhS3HzTo0-IY4LYF-ndEscBQdBYwRSUnqTvpZm1IQlWPy7M-rC_VscCua8hOUQwtK7OzpV-48ut2_l_ng-_0zfJ</recordid><startdate>20230623</startdate><enddate>20230623</enddate><creator>WEBERHOF CHRISTIAN</creator><creator>BRUMMEL CHRISTIAN</creator><creator>RAUM TOBIAS</creator><creator>BAILIS JULIE</creator><creator>EVOETS STEVEN</creator><creator>S. WEDLER</creator><creator>FAN ERIC</creator><creator>KLINGER MARKUS</creator><creator>WAHL JOACHIM</creator><creator>THOMAS OLIVER</creator><creator>BROSE JOHN</creator><creator>ZALESKI ADAM</creator><creator>LATEBIS PAUL</creator><creator>D 'ANGELO IVAN</creator><creator>LOWE DAVID</creator><creator>MOOZ MICHAEL</creator><creator>BOEHM THOMAS</creator><creator>NEGELE VOLKER</creator><creator>KUFER PETER</creator><creator>RATH BENEDIKT</creator><creator>ULRICH INGMAR</creator><scope>EVB</scope></search><sort><creationdate>20230623</creationdate><title>Multi-targeting bispecific antigen binding molecules with increased selectivity</title><author>WEBERHOF CHRISTIAN ; BRUMMEL CHRISTIAN ; RAUM TOBIAS ; BAILIS JULIE ; EVOETS STEVEN ; S. WEDLER ; FAN ERIC ; KLINGER MARKUS ; WAHL JOACHIM ; THOMAS OLIVER ; BROSE JOHN ; ZALESKI ADAM ; LATEBIS PAUL ; D 'ANGELO IVAN ; LOWE DAVID ; MOOZ MICHAEL ; BOEHM THOMAS ; NEGELE VOLKER ; KUFER PETER ; RATH BENEDIKT ; ULRICH INGMAR</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN116323671A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2023</creationdate><topic>CHEMISTRY</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><toplevel>online_resources</toplevel><creatorcontrib>WEBERHOF CHRISTIAN</creatorcontrib><creatorcontrib>BRUMMEL CHRISTIAN</creatorcontrib><creatorcontrib>RAUM TOBIAS</creatorcontrib><creatorcontrib>BAILIS JULIE</creatorcontrib><creatorcontrib>EVOETS STEVEN</creatorcontrib><creatorcontrib>S. WEDLER</creatorcontrib><creatorcontrib>FAN ERIC</creatorcontrib><creatorcontrib>KLINGER MARKUS</creatorcontrib><creatorcontrib>WAHL JOACHIM</creatorcontrib><creatorcontrib>THOMAS OLIVER</creatorcontrib><creatorcontrib>BROSE JOHN</creatorcontrib><creatorcontrib>ZALESKI ADAM</creatorcontrib><creatorcontrib>LATEBIS PAUL</creatorcontrib><creatorcontrib>D 'ANGELO IVAN</creatorcontrib><creatorcontrib>LOWE DAVID</creatorcontrib><creatorcontrib>MOOZ MICHAEL</creatorcontrib><creatorcontrib>BOEHM THOMAS</creatorcontrib><creatorcontrib>NEGELE VOLKER</creatorcontrib><creatorcontrib>KUFER PETER</creatorcontrib><creatorcontrib>RATH BENEDIKT</creatorcontrib><creatorcontrib>ULRICH INGMAR</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>WEBERHOF CHRISTIAN</au><au>BRUMMEL CHRISTIAN</au><au>RAUM TOBIAS</au><au>BAILIS JULIE</au><au>EVOETS STEVEN</au><au>S. WEDLER</au><au>FAN ERIC</au><au>KLINGER MARKUS</au><au>WAHL JOACHIM</au><au>THOMAS OLIVER</au><au>BROSE JOHN</au><au>ZALESKI ADAM</au><au>LATEBIS PAUL</au><au>D 'ANGELO IVAN</au><au>LOWE DAVID</au><au>MOOZ MICHAEL</au><au>BOEHM THOMAS</au><au>NEGELE VOLKER</au><au>KUFER PETER</au><au>RATH BENEDIKT</au><au>ULRICH INGMAR</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Multi-targeting bispecific antigen binding molecules with increased selectivity</title><date>2023-06-23</date><risdate>2023</risdate><abstract>The present invention provides a multi-targeting bispecific antigen-binding molecule characterized by comprising a first and a second bispecific entity, each entity comprising a domain that binds to a target, a second domain that binds to an extracellular epitope of human and macaque CD3 epsilon chains wherein the two bispecific entities are linked to each other by a spacer, the spacer separates the first and second bispecific entities. In addition, the invention provides polynucleotides encoding the multi-targeting bispecific antigen binding molecules, vectors comprising such polynucleotides, host cells expressing constructs, and pharmaceutical compositions comprising the same.
本发明提供了多靶向性双特异性抗原结合分子,其特征在于包含第一和第二双特异性实体,每个实体包含与靶标结合的结构域、与人和猕猴CD3ε链的细胞外表位结合的第二结构域,其中两个双特异性实体通过间隔物彼此连接,该间隔物将第一和第二双特异性实体间隔开。此外,本发明提供了编码该多靶向性双特异性抗原结合分子的多核苷酸、包含这种多核苷酸的载体、表达构建体的宿主细胞、以及包含其的药物组合物。</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | chi ; eng |
recordid | cdi_epo_espacenet_CN116323671A |
source | esp@cenet |
subjects | CHEMISTRY METALLURGY ORGANIC CHEMISTRY PEPTIDES |
title | Multi-targeting bispecific antigen binding molecules with increased selectivity |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T04%3A58%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=WEBERHOF%20CHRISTIAN&rft.date=2023-06-23&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN116323671A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |